| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/11/2012 | CN101346353B Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 01/11/2012 | CN101317841B Annonaceous acetogenin high-efficiency part medicine-Ainuoning, preparation method and application thereof |
| 01/11/2012 | CN101190281B Prune tree extract and preparation method and application thereof |
| 01/11/2012 | CN101108250B Mono- and disaccharide derivatives |
| 01/10/2012 | US8093392 Caspase inhibitors and uses thereof |
| 01/10/2012 | US8093301 Anti-allergic agent |
| 01/10/2012 | US8093278 Substituted indoles |
| 01/10/2012 | US8092809 Pseudomonas exotoxin A-like chimeric immunogens |
| 01/10/2012 | US8092780 Polyvalent conjugate vaccine for cancer |
| 01/10/2012 | US8092608 Administering oligosaccharides |
| 01/10/2012 | CA2486183C Protein kinase inhibitors |
| 01/10/2012 | CA2464334C Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 01/10/2012 | CA2455559C Methods to mobilize progenitor/stem cells |
| 01/10/2012 | CA2436665C Nucleic acid derivatives |
| 01/10/2012 | CA2382105C Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 01/10/2012 | CA2366314C Protein d from haemophilus influenzae as a carrier protein in combination vaccines |
| 01/10/2012 | CA2334483C Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 01/10/2012 | CA2246760C Polysaccharide-peptide-conjugates |
| 01/10/2012 | CA2124259C Galenical formulations |
| 01/05/2012 | WO2012003387A1 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | WO2012003264A1 Nitrogen containing heterocyclic compounds as pik3 -delta inhibitors |
| 01/05/2012 | WO2012002762A2 Peptide for the treatment or prevention of allergic diseases |
| 01/05/2012 | WO2012002582A1 Partial region polypeptide of reic/dkk-3 protein |
| 01/05/2012 | WO2012002577A1 Novel nicotinamide derivatives or salts thereof |
| 01/05/2012 | WO2012002502A1 Dihydropyrimidinone derivative and pharmaceutical use thereof |
| 01/05/2012 | WO2012000970A1 Triazolopyridines as tyk2 inhibitors |
| 01/05/2012 | WO2012000082A1 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-l-like receptor ligand or a nod-like receptor ligand to enhance the innate immune response |
| 01/05/2012 | WO2012000065A1 Treatment of t-cell mediated immune disorders |
| 01/05/2012 | WO2012000064A1 Method of treating graft versus host disease |
| 01/05/2012 | WO2011140634A3 The n-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
| 01/05/2012 | WO2011133227A3 Synthetic oligosaccharides for staphyloccocus vaccine |
| 01/05/2012 | WO2011115728A3 Polynucleotides that stimulate neutrophils |
| 01/05/2012 | WO2011094598A3 Compositions and methods for reversing corticosteroid resistance or treating respiratory infections |
| 01/05/2012 | WO2011088229A3 Active self-healing biomaterial system |
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004267 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | US20120004261 Mif modulators |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004237 Salt of cd 80 antagonist |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004211 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004201 Phosphodiestarase inhibitors |
| 01/05/2012 | US20120004200 Topical pharmaceutical composition containing a water-sensitive active principle |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004174 Gh secretagogues and uses thereof |
| 01/05/2012 | US20120004160 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
| 01/05/2012 | US20120003320 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |
| 01/05/2012 | US20120003316 Transmucosal delivery system |
| 01/05/2012 | US20120003306 Pharmaceutical composition of nanoparticles for protein drug delivery |
| 01/05/2012 | US20120003302 Pharmaceutical composition containing a fermented, dehydrated material with amorphous crystalline structure |
| 01/05/2012 | US20120003298 Methods for inducing an immune response |
| 01/05/2012 | US20120003295 Lipid a and other carbohydrate ligand analogs |
| 01/05/2012 | US20120003277 Nanoemulsion vaccines |
| 01/05/2012 | US20120003270 6-substituted isoflavonoid compounds and uses thereof |
| 01/05/2012 | US20120003269 Compositions Produced Using Enteric Pathogens and Methods of Use |
| 01/05/2012 | US20120003268 Synergistic combination and method thereof |
| 01/05/2012 | US20120003265 Immunogenic compositions for inducing an immune response to hiv |
| 01/05/2012 | US20120003263 Recombinant raccoon pox virus vaccine against highly pathogenic avian influenza |
| 01/05/2012 | US20120003260 Solid-Phase and Solution-Phase Synthesis of Glycosylphosphatidylinositol Glycans |
| 01/05/2012 | US20120003259 Molecule |
| 01/05/2012 | US20120003257 Recombinant avian infectious coryza vaccine and process for preparing same |
| 01/05/2012 | US20120003256 Tuberculosis antigens, immunogenic compositions, diagnostics and methods related to the same |
| 01/05/2012 | US20120003254 Breast Cancer Vaccine |
| 01/05/2012 | US20120003253 C1orf59 peptides and vaccines including the same |
| 01/05/2012 | US20120003250 Pharmaceutical composition with immunomodulating function |
| 01/05/2012 | US20120003241 Vaccine against botulism |
| 01/05/2012 | US20120003231 Cell surface molecule mediating cell adhesion and signal transmission |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | US20120003228 Methods for predicting autoimmune disease risk |
| 01/05/2012 | US20120003220 B7-DC Variants |
| 01/05/2012 | US20120003186 Method for dedifferentiating adipose tissue stromal cells |
| 01/05/2012 | US20120003175 Therapeutic uses of mastic gum fractions |
| 01/05/2012 | CA2807303A1 Inhibition of inflammation by simultaneous blockade of multiple prostanoid receptors |
| 01/05/2012 | CA2803989A1 Env trimer immunogens |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/05/2012 | CA2803641A1 Treatment of t-cell mediated immune disorders |
| 01/05/2012 | CA2803639A1 Method of treating graft versus host disease |
| 01/05/2012 | CA2803620A1 Heterocyclic compounds and their uses |
| 01/05/2012 | CA2803444A1 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-l-like receptor ligand or a nod-like receptor ligand to enhance the innate immune response |
| 01/05/2012 | CA2803298A1 Compositions and methods related to protein a (spa) variants |
| 01/05/2012 | CA2802743A1 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | CA2798028A1 Liquid formulations of rupatadine fumarate |
| 01/04/2012 | EP2402445A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/04/2012 | EP2402432A1 Immunopotentiating fermented food obtained from fructan-containing food |
| 01/04/2012 | EP2402349A1 Tricyclic pyrazolopyrimidine derivative |
| 01/04/2012 | EP2402316A1 Piperidine derivatives |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402034A1 A method for screening for a substance having an action of proliferating natural killer cells |
| 01/04/2012 | EP2402031A1 Immunologic adjuvant composition and use thereof |
| 01/04/2012 | EP2402020A1 Pharmaceutical composition comprising extracts of Bupleurum with immunomodulating function |
| 01/04/2012 | EP2402012A2 Liquid formulations of rupatadine fumarate |
| 01/04/2012 | EP2401300A1 ANTI-C mX ANTIBODIES CAPABLE OF BINDING TO HUMAN mIgE ON B LYMPHOCYTES |
| 01/04/2012 | EP2401273A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/04/2012 | EP2401270A1 Pyrazole derivatives used as ccr4 receptor antagonists |